Literature DB >> 20386865

Molecular mechanisms involved in the interaction effects of alcohol and hepatitis C virus in liver cirrhosis.

Valeria R Mas1, Ryan Fassnacht, Kellie J Archer, Daniel Maluf.   

Abstract

The mechanisms by which alcohol consumption accelerates liver disease in patients with chronic hepatitis C virus (HCV) are not well understood. To identify the characteristics of molecular pathways affected by alcohol in HCV patients, we fit probe-set level linear models that included the additive effects as well as the interaction between alcohol and HCV. The study included liver tissue samples from 78 patients, 23 (29.5%) with HCV-cirrhosis, 13 (16.7%) with alcohol-cirrhosis, 23 (29.5%) with HCV/alcohol cirrhosis and 19 (24.4%) with no liver disease (no HCV/no alcohol group). We performed gene-expression profiling by using microarrays. Probe-set expression summaries were calculated by using the robust multiarray average. Probe-set level linear models were fit where probe-set expression was modeled by HCV status, alcohol status, and the interaction between HCV and alcohol. We found that 2172 probe sets (1895 genes) were differentially expressed between HCV cirrhosis versus alcoholic cirrhosis groups. Genes involved in the virus response and the immune response were the more important upregulated genes in HCV cirrhosis. Genes involved in apoptosis regulation were also overexpressed in HCV cirrhosis. Genes of the cytochrome P450 superfamily of enzymes were upregulated in alcoholic cirrhosis, and 1230 probe sets (1051 genes) had a significant interaction estimate. Cell death and cellular growth and proliferation were affected by the interaction between HCV and alcohol. Immune response and response to the virus genes were downregulated in HCV-alcohol interaction (interaction term alcohol*HCV). Alcohol*HCV in the cirrhotic tissues resulted in a strong negative regulation of the apoptosis pattern with concomitant positive regulation of cellular division and proliferation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20386865      PMCID: PMC2896468          DOI: 10.2119/molmed.2009.00165

Source DB:  PubMed          Journal:  Mol Med        ISSN: 1076-1551            Impact factor:   6.354


  36 in total

1.  Assessment of liver histology in chronic alcoholics with and without hepatitis C virus infection.

Authors:  S Anderson; C L Nevins; L K Green; H El-Zimaity; B S Anand
Journal:  Dig Dis Sci       Date:  2001-07       Impact factor: 3.199

2.  Microarray analysis of gene expression in rat hippocampus after chronic ethanol treatment.

Authors:  Mariko Saito; John Smiley; Reka Toth; Csaba Vadasz
Journal:  Neurochem Res       Date:  2002-10       Impact factor: 3.996

3.  Effects of alcohol consumption on histological changes in chronic hepatitis C: a clinicopathological study.

Authors:  T Tamai; T Seki; T Shiro; T Nakagawa; M Wakabayashi; M Imamura; A Nishimura; N Yamashiki; M Takasu; K Inoue; A Okamura
Journal:  Alcohol Clin Exp Res       Date:  2000-04       Impact factor: 3.455

4.  Hepatitis C virus core protein, cytochrome P450 2E1, and alcohol produce combined mitochondrial injury and cytotoxicity in hepatoma cells.

Authors:  Kazuhiro Otani; Masaaki Korenaga; Michael R Beard; Kui Li; Ting Qian; Lori A Showalter; Aman K Singh; Ting Wang; Steven A Weinman
Journal:  Gastroenterology       Date:  2005-01       Impact factor: 22.682

Review 5.  Pathogenesis of chronic hepatitis C: immunological features of hepatic injury and viral persistence.

Authors:  A Cerny; F V Chisari
Journal:  Hepatology       Date:  1999-09       Impact factor: 17.425

Review 6.  Hepatitis C and alcohol: interactions, outcomes, and implications.

Authors:  Renuka Bhattacharya; Margaret C Shuhart
Journal:  J Clin Gastroenterol       Date:  2003-03       Impact factor: 3.062

7.  Insights into the pathobiology of hepatitis C virus-associated cirrhosis: analysis of intrahepatic differential gene expression.

Authors:  Nicholas A Shackel; Peter H McGuinness; Catherine A Abbott; Mark D Gorrell; Geoffrey W McCaughan
Journal:  Am J Pathol       Date:  2002-02       Impact factor: 4.307

Review 8.  Alcohol and hepatitis C.

Authors:  Kamran Safdar; Eugene R Schiff
Journal:  Semin Liver Dis       Date:  2004-08       Impact factor: 6.115

Review 9.  Liver disease in alcohol and hepatitis C.

Authors:  M Mazen Jamal; Timothy R Morgan
Journal:  Best Pract Res Clin Gastroenterol       Date:  2003-08       Impact factor: 3.043

10.  Elevation of interleukin-18 in chronic hepatitis C: implications for hepatitis C virus pathogenesis.

Authors:  Arpita Sharma; Anuradha Chakraborti; Ashim Das; Radha Krishan Dhiman; Yogesh Chawla
Journal:  Immunology       Date:  2008-11-24       Impact factor: 7.397

View more
  11 in total

Review 1.  Molecular changes in hepatic metabolism and transport in cirrhosis and their functional importance.

Authors:  Christoph G Dietrich; Oliver Götze; Andreas Geier
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

Review 2.  Extracellular matrix and liver disease.

Authors:  Elena Arriazu; Marina Ruiz de Galarreta; Francisco Javier Cubero; Marta Varela-Rey; María Pilar Pérez de Obanos; Tung Ming Leung; Aritz Lopategi; Aitor Benedicto; Ioana Abraham-Enachescu; Natalia Nieto
Journal:  Antioxid Redox Signal       Date:  2014-01-08       Impact factor: 8.401

3.  Stemness-related transcriptional factors and homing gene expression profiles in hepatic differentiation and cancer.

Authors:  Eman A Toraih; Manal S Fawzy; Abdullah I El-Falouji; Elham O Hamed; Nader A Nemr; Mohammad H Hussein; Noha M Abd El Fadeal
Journal:  Mol Med       Date:  2016-09-12       Impact factor: 6.354

Review 4.  Inflammatory status in human hepatic cirrhosis.

Authors:  María Martínez-Esparza; María Tristán-Manzano; Antonio J Ruiz-Alcaraz; Pilar García-Peñarrubia
Journal:  World J Gastroenterol       Date:  2015-11-07       Impact factor: 5.742

5.  ENCODE tiling array analysis identifies differentially expressed annotated and novel 5' capped RNAs in hepatitis C infected liver.

Authors:  Milan E Folkers; Don A Delker; Christopher I Maxwell; Cassie A Nelson; Jason J Schwartz; David A Nix; Curt H Hagedorn
Journal:  PLoS One       Date:  2011-02-16       Impact factor: 3.240

Review 6.  Current status and future directions in the management of chronic hepatitis C.

Authors:  Wosen Aman; Shaymaa Mousa; Gamal Shiha; Shaker A Mousa
Journal:  Virol J       Date:  2012-03-02       Impact factor: 4.099

Review 7.  Update on Alcohol and Viral Hepatitis.

Authors:  Stefano Gitto; Giovanni Vitale; Erica Villa; Pietro Andreone
Journal:  J Clin Transl Hepatol       Date:  2014-12-15

8.  Screening of differentially expressed protein kinases in bone marrow endothelial cells and the protective effects of the p38a inhibitor SB203580 on bone marrow in liver fibrosis.

Authors:  Bo Gao; Wang Sun; Xianzhi Meng; Dongbo Xue; Weihui Zhang
Journal:  Mol Med Rep       Date:  2016-10-12       Impact factor: 2.952

9.  Proteomic study of advanced cirrhosis based on HCV to reveal potential biomarkers.

Authors:  Akram Safaei; Afsaneh Arefi Oskouie; Seyed Reza Mohebbi; Zahra Razaghi; Naser Nejadi
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2020

10.  The peritoneal macrophage inflammatory profile in cirrhosis depends on the alcoholic or hepatitis C viral etiology and is related to ERK phosphorylation.

Authors:  Ana Tapia-Abellán; María Martínez-Esparza; Antonio J Ruiz-Alcaraz; Trinidad Hernández-Caselles; Cristina Martínez-Pascual; Manuel Miras-López; José Such; Rubén Francés; Pilar García-Peñarrubia
Journal:  BMC Immunol       Date:  2012-08-06       Impact factor: 3.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.